Seroprevalence of HBV and HCV markers among young adult males in the air force in Florianópolis, South Brazil

Brazilian Journal of Pharmaceutical Sciences

Volumn 48, Issue 2, 2012, Pages 257-264

  Passos, Ana Maria ^a   Neto, Miguel Strazer ^a   Treitinger, Aricio ^a   Spada, Celso ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

HBV; HCV; Hepatitis B; Hepatitis C; Seroprevalence

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY;

ADULT; AIR FORCE; ARTICLE; BLOOD ANALYSIS; BRAZIL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROPARTICLE ENZYME IMMUNOASSAY; NONHUMAN; POPULATION RESEARCH; RISK ASSESSMENT; RISK FACTOR; SEROLOGY; SEROPREVALENCE; UNSAFE SEX;

EID: 84867710748     PISSN: 19848250     EISSN: 21759790     Source Type: Journal    
DOI: 10.1590/S1984-82502012000200009     Document Type: Article

References (26)

1. ANTUNES, H.; MACEDO, M.; ESTRADA, A. Taxa de cobertura vacinal com imunização para o vírus da hepatite B. Acta Med. Port., v.17, p.303-308, 2004
2. BALOGUN, M.A.; RAMSAY, M.E.; HESKETH, L.M.; ANDREWS, N.; OSBORNE, K.P.; GAY, N.J.; MORGANCAPNER, P. The prevalence of hepatitis C in England and Wales. J. Infect., v.45, p.219-226, 2002.
3. BUT, D.Y.; LAI, C.L.; LIM, W.L.; FUNG, J.; WONG, D.K.; YUEN, M.F. Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report. Vaccine, v.26, p.6587-6591, 2008.
4. FABRIS, P.; BALDO, V.; BALDOVIN, T.; BELLOTTO, E.; RASSU, M.; TRIVELLO, R.; TRAMARIN, A.; TOSITTI, G.; FLOREANI, A. Changing Epidemiology of HCV and HBV Infections in Northern Italy: A Survey in the General Population. J. Clin. Gastroenterol., v.42, p.527-532, 2008.
5. GERMAN, V.; GIANNAKOS, G.; KOPTERIDES, P.; LIASKONIS, K.; FALAGAS, M.E. Serologic indices of hepatitis B virus infection in military recruits in Greece (2004-2005). BMC Infect. Dis., v.6, p.163, 2006.
6. HAMMITT, L.L; HENNESSY, T.W.; FIORE, A.E.; ZANIS, C.; HUMMEL, K.B.; DUNAWAY, E.; BULKOW, L.; MCMAHON, B.J. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine, v.25, p.6958-6964, 2007.
7. KNOLL, A.; HARTMANN, A.; HAMOSHI, H.; WEISLMAIER, K.; JILG, W. Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance. World J. Gastroenterol., v.28, p.1255-1260, 2006.
8. KOYA, D.L.; HILL, E.G.; DARDEN, P.M. The effect of vaccinated children on increased hepatitis B immunization among high-risk adults. Am. J. Public Health, v.98, p.832-838, 2008.
9. MARTELLI, C.M.; TURCHI, M.; SOUTO, F.J.; SAEZALQUEZAR, A.; ANDRADE, A.L.; ZICKER, F. Anti-HBc testing for blood donations in areas with intermediate hepatitis B endemicity. Rev. Panam. Salud Publica, v.6, p.69-73, 1999.
10. Mcquillan, G.M.; Coleman, P.J.; Kruszon-Moran, D.; Moyer, L.A.; Lambert, S.B.; Margolis, H.S. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am. J. Public Health, v.89, p.14-18, 1999.
11. MINISTÉRIO DA SAÚDE. Hepatites virais: O Brasil está atento. 3.ed. Brasília, DF: Ministério da Saúde, 2008. 60p.
12. MINISTÉRIO DA SAÚDE. Programa nacional de imunizações: PNI 30 anos. Brasília, DF: Fundação Nacional de Saúde, 2003. 208p.
13. MOTTA, V.T.; WAGNER, M.B. Bioestatística. Caxias do Sul: Educs; São Paulo: Robe Editorial, 2003. 201p.
14. NASCIMENTO, M.C.; MAYAUD, P.; SABINO, E.C.; TORRES, K.L., FRANCESCHI, S. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey. J. Med. Virol., v.80, p.53-57, 2008.
15. PEREIRA, L.M.M.B.; MARTELLI, C.M.T.; MERCHÁNHAMANN, E.; MONTARROYOS, U.R.; BRAGA, M.C.; LIMA, M.L.C.; CARDOSO, M.R.A.; TURCHI, M.D.; COSTA, M.A.; ALENCAR, L.C.A.; MOREIRA, R.C.; FIGUEIREDO, G.M.; XIMENES, R.A.A. Populationbased multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil. Am. J. Trop. Med. Hyg., v.81, p.240-247, 2009.
16. ROSINI, N.; MOUSSE, D.; SPADA, C.; TREITINGER, A. Seroprevelence of HbsAg, anti-HBc and anti-HCV in Southern Brazil, 1999-2001. Braz. J. Infect. Dis., v.7, p.262-267, 2003.
17. SCARAVELI, N.G.; PASSOS, A.M.; VOIGT, A.R.; LIVRAMENTO, A.; TONIAL, G.; TREITINGER, A.; SPADA, C. Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil. Cad. Saúde Pública, v.27, p.753-758, 2011.
18. SCOTT, P.T.; NIEBUHR, D.W.; MCGREADY, J.B.; GAYDOS, J.C. Hepatitis B immunity in United States military recruits. J. Infect. Dis., v.191, p.1835-1841, 2005.
19. TOLEDO, A.C.; GRECO, D.B.; FELGA, M.; BARREIRA, D.; GADELHA, M.D.E.; SPERANZA, F.A. Seroprevalence of hepatitis B and C in Brazilian army conscripts in 2002: a cross-sectional study. Braz. J. Infect. Dis., v.9, p.374-383, 2005.
20. TONIAL, G.; PASSOS, A.M.; LIVRAMENTO, A.; SCARAVELI, N.G.; BATSCHAUER, A.P.B.; BUENO, E.C.; LARGURA, A.; SPADA, C.; TREITINGER, A. Hepatitis B marker seroprevalence and vaccination coverage in adolescents in the City of Itajaí, State of Santa Catarina, Southern Brazil, in 2008. Rev. Soc. Bras. Med. Trop., v.44, p.416-419, 2011.
21. VOIGT, A.R.; STRAZER NETO, M.; SPADA, C.; TREITINGER, A. Seroprevalence of hepatitis B and hepatitis C markers amon children and adolescents in the South Brazilian Region - Metropolitan Area of Florianópolis, Santa Catarina. Braz. J. Infect. Dis., v.14, p.60-65, 2010.
22. WORLD HEALTH ORGANIZATION. Global distribution of hepatitis A, B and C, 2001. Wkly. Epidemiol. Rec., v.77, p.46-47, 2002.
23. WORLD HEALTH ORGANIZATION. Hepatitis B vaccines. Wkly. Epidemiol. Rec., v.84, p.405-420, 2009.
24. WORLD HEALTH ORGANIZATION. Hepatitis C - global prevalence (update). Wkly. Epidemiol. Rec., v.74, p.425-427, 1999.
25. Ximenes, R.A.A.; Pereira, L.M.B.; Mertelli, C.M.T.; Merchán-Hamann, E.; Stein, A.T.; Figueiredo, G.M.; Braga, M.C.; Montarroyos, U.R.; Brasil, L.M.; Turchi, M.D.; Fonseca, J.C.F.; Lima, M.L.C.; Alencar, L.C.A.; Costa, M.; Coral, G.; Moreira, R.C.; Cardoso, M.R.A. Methodology of a nationwide cross-sectional survey of prevalence and epidemiological patterns of hepatitis A, B and C infection in Brazil. Cad. Saúde Pública, v.26, p.1693-1704, 2010.
26. Zanetti, A.R.; Mariano, A.; Romanò, L.; D'amelio, R.; Chironna, M.; Coppola, R.C.; Cuccia, M.; Mangione, R.; Marrone, F.; Negrone, F.S.; Parlato, A.; Zamparo, E.; Zotti, C.; Stroffolini, T.; Mele, A. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet, v.366, p.1379-1384, 2005.